...
By 1997 he became the Assistant Director for Science at the FDA’s Center for Biologics Evaluation and Research (CBER), the ultimate successor to DBS. He retired in 2004 but continued to volunteer part-time at the FDA through 2014. He spent his entire 56-year career on the NIH campus, the first two years in Building 8, and then in Building 29. He passed away in 2020.
| Info |
|---|
Dr. Finlayson worked in Building 29, first floor when his lab was part of the NIH. After the transition to the FDA, the Laboratory of Blood and Blood Products moved to the second and third floors of Building 29. |
...
Overview
Content Tools
ThemeBuilder